<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02365259</url>
  </required_header>
  <id_info>
    <org_study_id>15178</org_study_id>
    <nct_id>NCT02365259</nct_id>
  </id_info>
  <brief_title>Phototherapy in Persons With Multiple Sclerosis</brief_title>
  <official_title>Effect of UVB Phototherapy on Serum Vitamin D in Persons With Multiple Sclerosis; a Placebo Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Illinois at Urbana-Champaign</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Illinois at Urbana-Champaign</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The current study examines the effect of phototherapy equipped with Narrow Band UVB lamps on
      vitamin D production in persons with MS.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants will be exposed to phototherapy according to the 2014 Guidelines issued by the
      American Academy of Dermatology 3 days per week over an 8-week period.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">February 2016</completion_date>
  <primary_completion_date type="Anticipated">February 2016</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Baseline in Serum Vitamin D at 4 and 8 weeks</measure>
    <time_frame>0, 4, and 8 weeks</time_frame>
    <description>Venous blood will be collected to quantify levels of circulating Vitamin D.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Walking Speed at 4 and 8 weeks</measure>
    <time_frame>0, 4, and 8 weeks</time_frame>
    <description>Participants will walking for 25-feet as fast, but safely, as possible on an instrumented gait mat for measuring gait speed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Cognitive Function at 4 and 8 weeks</measure>
    <time_frame>0, 4, and 8 weeks</time_frame>
    <description>Participants will complete neuropsychological assessments of processing speed and learning and memory.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Mood State at 4 and 8 weeks</measure>
    <time_frame>0, 4, and 8 weeks</time_frame>
    <description>Participants will complete a 30-item self-report measure of overall mood.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Multiple Sclerosis</condition>
  <arm_group>
    <arm_group_label>Phototherapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This arm involves exposure to a UVB phototherapy device 3 times per week over 8 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Shame phototherapy</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>This arm is identical with experimental arm, except that participants will be exposed to non-UVB florescent light.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Phototherapy</intervention_name>
    <description>Participants will be exposed to phototherapy according to the 2014 Guidelines issued by the American Academy of Dermatology 3 days per week over an 8-week period.</description>
    <arm_group_label>Phototherapy</arm_group_label>
    <arm_group_label>Shame phototherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female with multiple sclerosis

        Exclusion Criteria:

          -  Inability to stand still in a stabilized fashion without risk of falling for up to 6
             minutes

          -  Known medical history of calcium disorder or knowledge of high calcium levels

          -  Known medical history of hyper-parathyroidism

          -  Current supplementation with oral vitamin D

          -  Known allergy to vitamin D

          -  History of cancer of any type including but not limited to skin cancer

          -  Obesity defined as BMI &gt; 30

          -  Known history of fat malabsorption conditions (i.e., steatorrhea)

          -  Current use of anti-epileptic medication

          -  Current use of glucocorticoids

          -  Fitzpatrick skin types I and VI using the Fitzpatrick skin type analysis

          -  Recent use of tanning facilities
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert W Motl, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Illinois at Urbana-Champaign</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Exercise Neuroscience Research Laboratory</name>
      <address>
        <city>Urbana</city>
        <state>Illinois</state>
        <zip>61801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 2, 2015</study_first_submitted>
  <study_first_submitted_qc>February 10, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 18, 2015</study_first_posted>
  <last_update_submitted>February 10, 2015</last_update_submitted>
  <last_update_submitted_qc>February 10, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 18, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sclerosis</mesh_term>
    <mesh_term>Multiple Sclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

